(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1319886 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RARRES1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1551283 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RARRES1 mRNA CTD PMID:36331819 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of RARRES1 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:1319886 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RARRES1 mRNA CTD PMID:17404688 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RARRES1 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RARRES1 mRNA CTD PMID:32741896 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20056577 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:1319886 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319886 6480464 Tetrachlorodibenzodioxin results in decreased expression of RARRES1 mRNA CTD PMID:21296121 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RARRES1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551283 6480464 Tetrachlorodibenzodioxin results in decreased expression of RARRES1 mRNA CTD PMID:19770486 , PMID:25270620 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of RARRES1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of RARRES1 mRNA CTD PMID:21346803 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of RARRES1 mRNA CTD PMID:28300664 3,4-dichloroaniline increases expression ISO RGD:1319886 6480464 3, 4-dichloroaniline results in increased expression of RARRES1 mRNA CTD PMID:24172598 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1319886 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RARRES1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO RGD:1319886 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of RARRES1 mRNA CTD PMID:25912373 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of RARRES1 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:1551283 6480464 Fenretinide results in increased expression of RARRES1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1319886 6480464 [[Decitabine co-treated with trichostatin A] affects the methylation of RARRES1 promoter] which affects the expression of RARRES1 mRNA, Decitabine inhibits the reaction [Aflatoxin B1 results in decreased expression of RARRES1 mRNA] CTD PMID:18803327 , PMID:28458013 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of RARRES1 mRNA CTD PMID:24780913 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:1319886 6480464 apocarotenal results in increased expression of RARRES1 mRNA CTD PMID:17034753 9-cis-retinoic acid increases expression ISO RGD:1319886 6480464 Alitretinoin results in increased expression of RARRES1 mRNA CTD PMID:17034753 acetamide increases expression EXP 6480464 acetamide results in increased expression of RARRES1 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:1551283 6480464 Aflatoxin B1 results in decreased expression of RARRES1 mRNA CTD PMID:19770486 aflatoxin B1 multiple interactions ISO RGD:1319886 6480464 decitabine inhibits the reaction [Aflatoxin B1 results in decreased expression of RARRES1 mRNA] CTD PMID:28458013 aflatoxin B1 decreases expression ISO RGD:1319886 6480464 Aflatoxin B1 results in decreased expression of RARRES1 mRNA CTD PMID:28458013 aflatoxin B1 increases methylation ISO RGD:1319886 6480464 Aflatoxin B1 results in increased methylation of RARRES1 gene, Aflatoxin B1 results in increased methylation of RARRES1 intron CTD PMID:28458013 , PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:1319886 6480464 aflatoxin B2 results in increased methylation of RARRES1 intron CTD PMID:30157460 all-trans-4-oxoretinoic acid increases expression ISO RGD:1319886 6480464 4-oxoretinoic acid results in increased expression of RARRES1 mRNA CTD PMID:17034753 all-trans-4-oxoretinol increases expression ISO RGD:1319886 6480464 4-oxoretinol results in increased expression of RARRES1 mRNA CTD PMID:17034753 all-trans-retinoic acid increases expression ISO RGD:1319886 6480464 Tretinoin results in increased expression of RARRES1 mRNA CTD PMID:17034753 all-trans-retinol increases expression ISO RGD:1319886 6480464 Vitamin A results in increased expression of RARRES1 mRNA CTD PMID:17034753 amphotericin B decreases expression ISO RGD:1319886 6480464 Amphotericin B analog results in decreased expression of RARRES1 mRNA CTD PMID:28534445 antirheumatic drug decreases expression ISO RGD:1319886 6480464 Antirheumatic Agents results in decreased expression of RARRES1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1319886 6480464 aristolochic acid I results in increased expression of RARRES1 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1319886 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RARRES1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1319886 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RARRES1 mRNA CTD PMID:32525701 azathioprine increases expression ISO RGD:1319886 6480464 Azathioprine results in increased expression of RARRES1 mRNA CTD PMID:19192274 belinostat decreases expression ISO RGD:1319886 6480464 belinostat results in decreased expression of RARRES1 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:1551283 6480464 Benzo(a)pyrene results in decreased expression of RARRES1 mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene decreases methylation ISO RGD:1319886 6480464 Benzo(a)pyrene results in decreased methylation of RARRES1 5' UTR, Benzo(a)pyrene results in decreased methylation of RARRES1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1319886 6480464 Benzo(a)pyrene affects the methylation of RARRES1 intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1319886 6480464 7 more ... CTD PMID:20382639 beta-carotene increases expression ISO RGD:1319886 6480464 beta Carotene results in increased expression of RARRES1 mRNA CTD PMID:17034753 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1551283 6480464 Diethylhexyl Phthalate results in increased expression of RARRES1 mRNA CTD PMID:19850644 bisphenol A increases expression ISO RGD:1319886 6480464 bisphenol A results in increased expression of RARRES1 mRNA CTD PMID:22576693 bisphenol A increases expression ISO RGD:1551283 6480464 bisphenol A results in increased expression of RARRES1 mRNA CTD PMID:32156529 , PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RARRES1 mRNA CTD PMID:32145629 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RARRES1 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1319886 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RARRES1 mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:1319886 6480464 bisphenol A results in decreased expression of RARRES1 mRNA CTD PMID:25912373 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RARRES1 mRNA CTD PMID:25181051 butanal decreases expression ISO RGD:1319886 6480464 butyraldehyde results in decreased expression of RARRES1 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO RGD:1551283 6480464 Cadmium Chloride results in decreased expression of RARRES1 mRNA CTD PMID:24982889 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of RARRES1 mRNA CTD PMID:25993096 calcitriol increases expression ISO RGD:1319886 6480464 Calcitriol results in increased expression of RARRES1 mRNA CTD PMID:14996990 , PMID:26485663 carbon nanotube increases expression ISO RGD:1551283 6480464 Nanotubes, Carbon results in increased expression of RARRES1 mRNA CTD PMID:25620056 chlordecone increases expression ISO RGD:1551283 6480464 Chlordecone results in increased expression of RARRES1 mRNA CTD PMID:33711761 chlorpyrifos increases expression ISO RGD:1551283 6480464 Chlorpyrifos results in increased expression of RARRES1 mRNA CTD PMID:32715474 cisplatin multiple interactions ISO RGD:1319886 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of RARRES1 mRNA CTD PMID:27392435 clofibrate increases expression ISO RGD:1551283 6480464 Clofibrate results in increased expression of RARRES1 mRNA CTD PMID:30629241 cobalt dichloride decreases expression ISO RGD:1319886 6480464 cobaltous chloride results in decreased expression of RARRES1 mRNA CTD PMID:19376846 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of RARRES1 mRNA CTD PMID:27523638 dexamethasone decreases expression ISO RGD:1319886 6480464 Dexamethasone results in decreased expression of RARRES1 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1319886 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RARRES1 mRNA CTD PMID:28628672 dextran sulfate decreases expression ISO RGD:1551283 6480464 Dextran Sulfate results in decreased expression of RARRES1 mRNA CTD PMID:35093514 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of RARRES1 mRNA CTD PMID:33729688 diuron increases expression ISO RGD:1319886 6480464 Diuron metabolite results in increased expression of RARRES1 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1319886 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RARRES1 mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of RARRES1 mRNA CTD PMID:29391264 epoxiconazole affects expression ISO RGD:1551283 6480464 epoxiconazole affects the expression of RARRES1 mRNA CTD PMID:35436446 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of RARRES1 mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:1551283 6480464 Folic Acid results in decreased expression of RARRES1 mRNA CTD PMID:25629700 furan decreases expression EXP 6480464 furan results in decreased expression of RARRES1 mRNA CTD PMID:25539665 genistein increases expression ISO RGD:1551283 6480464 Genistein results in increased expression of RARRES1 mRNA CTD PMID:32186404 indometacin multiple interactions ISO RGD:1319886 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RARRES1 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:1551283 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RARRES1 mRNA CTD PMID:36331819 irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of RARRES1 mRNA CTD PMID:20097248 isotretinoin multiple interactions ISO RGD:1319886 6480464 AGN 193109 inhibits the reaction [Isotretinoin results in increased expression of RARRES1 mRNA] CTD PMID:16575387 isotretinoin increases expression ISO RGD:1319886 6480464 Isotretinoin results in increased expression of RARRES1 mRNA CTD PMID:16575387 lipopolysaccharide multiple interactions ISO RGD:1319886 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RARRES1 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:1319886 6480464 Lipopolysaccharides results in increased expression of RARRES1 mRNA CTD PMID:35811015 methotrexate increases expression ISO RGD:1319886 6480464 Methotrexate results in increased expression of RARRES1 mRNA CTD PMID:19192274 methylmercury chloride decreases expression ISO RGD:1319886 6480464 methylmercuric chloride results in decreased expression of RARRES1 mRNA CTD PMID:28001369 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of RARRES1 mRNA CTD PMID:24136188 paracetamol affects expression ISO RGD:1551283 6480464 Acetaminophen affects the expression of RARRES1 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:1551283 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of RARRES1 mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:1551283 6480464 Acetaminophen results in decreased expression of RARRES1 mRNA CTD PMID:29246445 paracetamol decreases expression ISO RGD:1319886 6480464 Acetaminophen results in decreased expression of RARRES1 mRNA CTD PMID:21420995 , PMID:29067470 parathion decreases expression ISO RGD:1551283 6480464 Parathion results in decreased expression of RARRES1 mRNA CTD PMID:34813904 paricalcitol multiple interactions ISO RGD:1319886 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of RARRES1 mRNA CTD PMID:17715259 perfluorohexanesulfonic acid increases expression ISO RGD:1551283 6480464 perfluorohexanesulfonic acid results in increased expression of RARRES1 mRNA CTD PMID:28558994 perfluorononanoic acid increases expression ISO RGD:1319886 6480464 perfluoro-n-nonanoic acid results in increased expression of RARRES1 mRNA CTD PMID:32588087 perfluorononanoic acid increases expression ISO RGD:1551283 6480464 perfluoro-n-nonanoic acid results in increased expression of RARRES1 mRNA CTD PMID:28558994 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1551283 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RARRES1 mRNA more ... CTD PMID:28558994 , PMID:36331819 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1319886 6480464 perfluorooctane sulfonic acid results in increased expression of RARRES1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1551283 6480464 perfluorooctane sulfonic acid results in increased expression of RARRES1 mRNA CTD PMID:28558994 perfluorooctanoic acid increases expression ISO RGD:1551283 6480464 perfluorooctanoic acid results in increased expression of RARRES1 mRNA CTD PMID:28558994 perfluorooctanoic acid increases expression ISO RGD:1319886 6480464 perfluorooctanoic acid results in increased expression of RARRES1 mRNA CTD PMID:32588087 permethrin increases expression ISO RGD:1551283 6480464 Permethrin results in increased expression of RARRES1 mRNA CTD PMID:30629241 phenobarbital increases expression ISO RGD:1551283 6480464 Phenobarbital results in increased expression of RARRES1 mRNA CTD PMID:19270015 , PMID:23091169 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1319886 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RARRES1 mRNA CTD PMID:16979875 phosphorus atom multiple interactions ISO RGD:1319886 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of RARRES1 mRNA CTD PMID:17715259 phosphorus atom decreases expression ISO RGD:1319886 6480464 Phosphorus results in decreased expression of RARRES1 mRNA CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:1319886 6480464 [Phosphorus co-treated with paricalcitol] results in increased expression of RARRES1 mRNA CTD PMID:17715259 phosphorus(.) decreases expression ISO RGD:1319886 6480464 Phosphorus results in decreased expression of RARRES1 mRNA CTD PMID:17715259 pirinixic acid multiple interactions ISO RGD:1319886 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RARRES1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1551283 6480464 pirinixic acid results in increased expression of RARRES1 mRNA CTD PMID:18301758 potassium chromate decreases expression ISO RGD:1319886 6480464 potassium chromate(VI) results in decreased expression of RARRES1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1319886 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RARRES1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1551283 6480464 Pregnenolone Carbonitrile results in increased expression of RARRES1 mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:1319886 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RARRES1 mRNA CTD PMID:17404688 progesterone increases expression ISO RGD:1319886 6480464 Progesterone results in increased expression of RARRES1 mRNA CTD PMID:21540246 propiconazole increases expression ISO RGD:1551283 6480464 propiconazole results in increased expression of RARRES1 mRNA CTD PMID:21278054 resveratrol multiple interactions ISO RGD:1551283 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of RARRES1 mRNA] CTD PMID:31298478 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of RARRES1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1319886 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RARRES1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1319886 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RARRES1 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1319886 6480464 Silicon Dioxide analog results in decreased expression of RARRES1 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1551283 6480464 Silver results in decreased expression of RARRES1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1551283 6480464 Silver results in decreased expression of RARRES1 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:1319886 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of RARRES1 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1319886 6480464 sodium arsenite results in increased expression of RARRES1 mRNA CTD PMID:29301061 , PMID:34032870 sodium aurothiomalate increases expression ISO RGD:1319886 6480464 Gold Sodium Thiomalate results in increased expression of RARRES1 mRNA CTD PMID:19192274 Soman increases expression EXP 6480464 Soman results in increased expression of RARRES1 mRNA CTD PMID:19281266 sulforaphane increases expression ISO RGD:1551283 6480464 sulforaphane results in increased expression of RARRES1 mRNA CTD PMID:30529165 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RARRES1 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:1551283 6480464 Carbon Tetrachloride results in increased expression of RARRES1 mRNA CTD PMID:31919559 thimerosal increases expression ISO RGD:1319886 6480464 Thimerosal results in increased expression of RARRES1 mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of RARRES1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:1551283 6480464 titanium dioxide results in decreased expression of RARRES1 mRNA CTD PMID:31298478 titanium dioxide multiple interactions ISO RGD:1551283 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of RARRES1 mRNA] CTD PMID:31298478 topotecan increases expression EXP 6480464 Topotecan results in increased expression of RARRES1 mRNA CTD PMID:25729387 trichostatin A multiple interactions ISO RGD:1319886 6480464 [[decitabine co-treated with trichostatin A] affects the methylation of RARRES1 promoter] which affects the expression of RARRES1 mRNA CTD PMID:18803327 trichostatin A increases expression ISO RGD:1319886 6480464 trichostatin A results in increased expression of RARRES1 mRNA CTD PMID:24935251 trichostatin A decreases expression ISO RGD:1319886 6480464 trichostatin A results in decreased expression of RARRES1 mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:1319886 6480464 Valproic Acid affects the expression of RARRES1 mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of RARRES1 mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:1319886 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RARRES1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1319886 6480464 Valproic Acid results in decreased expression of RARRES1 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:1319886 6480464 Valproic Acid results in increased expression of RARRES1 mRNA CTD PMID:24935251 zinc atom multiple interactions ISO RGD:1319886 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RARRES1 mRNA CTD PMID:16979875 zinc(0) multiple interactions ISO RGD:1319886 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RARRES1 mRNA CTD PMID:16979875
